MedDataX Logo

Clinical Characteristics and Outcome of Patients With Community Acquired Pneumonia

NCT ID: NCT06716099

Last Updated: 2024-12-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-12-15

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the goal of this observational study is to evaluate the clinical characteristic and outcomes of patients with community-acquired pneumonia admitted to Sohag University Hospital.

the researcher will take medical history and clinical examination and investigations of participants .

the participants will visit the clinic after one month to be reevaluated again .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Community acquired pneumonia is acute infection of the pulmonary parenchyma that occurs in the community in a patient who has not been hospitalized within 14 days prior to onset of symptoms or hospitalized less than 2 days prior to the onset of symptoms the aim of the study typically focuses on examining the various factors that influence the presentation, management, and outcomes of individuals diagnosed with pneumonia that is acquired outside of a hospital or healthcare setting.

Type of the study: observational study

Outcomes of interest include:

I. Mortality (in hospital and 30 days). II. The need for further mechanical ventilation or ICU admission. III. Duration of hospital stay.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Community Acquired Pneumonia (CAP)

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

CAP Pneumonia clinical characteristics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The study will include patients ≥18 years old with community acquired pneumonia

Exclusion Criteria

1. Patients already was diagnosed as active malignancy before admission
2. Patient on chemotherapy
3. HIV patients
4. Indication of mechanical ventilation on admission
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rania Abdo saeed

Rania Abdo Saeed

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rania Abdo Saeed Rania Abdo saeed, MBBCh

Role: CONTACT

Phone: +2001093776651

Email: [email protected]

References

Explore related publications, articles, or registry entries linked to this study.

Han X, Liu X, Chen L, Wang Y, Li H, Zhou F, Xing X, Zhang C, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu M, Xue C, Liu B, Zhu X, Li Y, Xiao Y, Cui X, Li L, Cao B; CAP-China network. Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients. BMC Infect Dis. 2020 Sep 12;20(1):668. doi: 10.1186/s12879-020-05362-3.

Reference Type RESULT
PMID: 32919458 (View on PubMed)

Iqbal N, Irfan M, Siddique F, Arshad V, Zubairi ABS. Factors predicting in-hospital mortality among patients admitted with community acquired pneumonia at a tertiary care hospital Karachi, Pakistan. Clin Respir J. 2020 Apr;14(4):328-334. doi: 10.1111/crj.13137. Epub 2020 Jan 2.

Reference Type RESULT
PMID: 31863551 (View on PubMed)

Elsener C, Beeler PE, Battegay E, Bello B, Thienemann F. Risk Factors of In-Hospital Mortality in Patients Treated for Pneumonia at a Tertiary Care Centre in Switzerland. Respiration. 2020;99(8):637-645. doi: 10.1159/000508666. Epub 2020 Jul 7.

Reference Type RESULT
PMID: 32634800 (View on PubMed)

Li HY, Guo Q, Song WD, Zhou YP, Li M, Chen XK, Liu H, Peng HL, Yu HQ, Chen X, Liu N, Lu ZD, Liang LH, Zhao QZ, Jiang M. Modified IDSA/ATS Minor Criteria for Severe Community-Acquired Pneumonia Best Predicted Mortality. Medicine (Baltimore). 2015 Sep;94(36):e1474. doi: 10.1097/MD.0000000000001474.

Reference Type RESULT
PMID: 26356705 (View on PubMed)

Shoar S, Musher DM. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia (Nathan). 2020 Oct 5;12:11. doi: 10.1186/s41479-020-00074-3. eCollection 2020.

Reference Type RESULT
PMID: 33024653 (View on PubMed)

1. Somberg J. Harrisons, Princiole of Internal Medicine. 20th ed. LWW; 2005

Reference Type RESULT

Related Links

Access external resources that provide additional context or updates about the study.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533148

Related Info

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med-24-09-01MS

Identifier Type: -

Identifier Source: org_study_id